Open AccessModification of the existing maximum residue levels for valifenalate in various crops
Author(s) -
Brancato Alba,
Brocca Daniela,
Carrasco Cabrera Luis,
De Lentdecker Chloe,
Erdos Zoltan,
Ferreira Lucien,
Greco Luna,
Jarrah Samira,
Kardassi Dimitra,
Leuschner Renata,
Lythgo Christopher,
Medina Paula,
Miron Ileana,
Molnar Tunde,
Pedersen Ragnor,
Reich Hermine,
Sacchi Angela,
Santos Miguel,
Stanek Alois,
Sturma Juergen,
Tarazona Jose,
Theobald Anne,
Vagenende Benedicte,
VillamarBouza Laura
Publication year - 2018
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2018.5289
Subject(s) - risk assessment , residue (chemistry) , enforcement , agriculture , crop , good agricultural practice , agricultural science , toxicology , business , microbiology and biotechnology , environmental science , agronomy , computer science , food security , biology , ecology , biochemistry , computer security , food systems
In accordance with Article 6 of Regulation ( EC ) No 396/2005, the applicant Belchim Crop Protection NV / SA submitted a request to the competent national authority in Hungary to modify the existing maximum residue levels ( MRL s) for the active substance valifenalate in various crops. The data submitted in support of the request were found to be sufficient to derive MRL proposals for lettuces, tomatoes, aubergines, onions, shallots and garlic. Adequate analytical methods for enforcement are available to control the residues of valifenalate on the commodities under consideration at the validated limit of quantification ( LOQ ) of 0.01 mg/kg. Based on the risk assessment results, EFSA concluded that the long‐term intake of residues resulting from the use of valifenalate according to the reported agricultural practices is unlikely to present a risk to consumer health. The short‐term intake was not carried out since no acute reference dose ( AR fD) is established for valifenalate. The reliable end points, appropriate for use in regulatory risk assessment are presented.